Latest Finjan Holdings Inc. (FNJN) Headlines Finjan

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Finjan Holdings Inc. (FNJN) Headlines

Finjan Holdings To Participate In 26th Annual ROTH Conference
PR Newswire - Mon Feb 24, 3:05PM CST
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company"), a leading online security and technology company, today announced it is scheduled to participate in the 26th Annual ROTH Conference being held March 9-12, 2014 at the Ritz-Carlton Laguna Niguel, CA. The Company is scheduled to present on Tuesday, March 11, 2014 at 4:30 pm Pacific Time, with one-on-one meetings held throughout the day.

Finjan Holdings Appoints Julie Mar-Spinola As Vice President, Legal Operations
PR Newswire - Tue Feb 11, 7:30AM CST
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced the appointment of Julie Mar-Spinola as Vice President, Legal Operations. In this newly created role, Ms. Mar-Spinola will join the Company's senior management team and have a dual business and legal role, including building up Finjan's Intellectual Property (IP) assets, heading up legal operations, and overseeing the Company's patent enforcement program to protect its proprietary technologies and IP. She will report to Finjan's President, Phil Hartstein.

Former Intel Executive Ivan Chaperot Joins Finjan Holdings As Vice President, IP Licensing
PR Newswire - Tue Feb 04, 7:30AM CST
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced that Ivan Chaperot has joined the Company as Vice President, Intellectual Property (IP) Licensing. In this newly created position, he will be responsible for leading Finjan's IP licensing programs. Mr. Chaperot brings a wealth of experience from working with some of the industry's leading technology and IP asset management companies. He is joining the Company as a member of the senior management team and will report directly to Finjan's President, Phil Hartstein.

Worlds names new board member
M2 - Thu Jan 30, 11:19AM CST
Worlds Inc. (OTCBB: WDDD) said it has added Ed Gildea as a member of its board of directors.

Finjan Holdings Subsidiary Files Patent Infringement Lawsuit Against Proofpoint And Subsidiary Armorize Technologies
PR Newswire - Tue Dec 17, 7:30AM CST
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced that its subsidiary, Finjan, Inc. (Finjan) has filed a patent infringement lawsuit against Proofpoint, Inc., and its subsidiary Armorize Technologies, Inc. alleging infringement of Finjan patents relating to endpoint, web, and network security technologies.

Finjan Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
PR Newswire - Mon Dec 09, 7:30AM CST
Finjan Holdings, Inc. (OTC: FNJN), a leading online security and technology company, today announced its December 5th RetailInvestorConferences.com presentation is now available for on-demand viewing.

Finjan Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 5th
PR Newswire - Tue Dec 03, 7:30AM CST
Finjan Holdings, Inc. (OTC: FNJN), a leading online security and technology company, today announced that Shimon Steinmetz, Chief Financial Officer, will present at RetailInvestorConferences.com.

NYSE, OTC and Nasdaq Companies Webcast to Online Investors: December 5th at RetailInvestorConferences.com
PR Newswire - Tue Dec 03, 6:30AM CST
PR Newswire, BetterInvesting, and MUNCmedia today announced the agenda of the upcoming RetailInvestorConferences.com, the monthly online investor conference series. Individual investors, institutional investors and analysts are invited.

Finjan Holdings Announces Equity Investment In Cybersecurity Focused Venture Capital Fund
PR Newswire - Thu Nov 21, 3:05PM CST
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") a leading online security and technology company, today announced a strategic investment in an Israel-based venture capital fund (the "Fund") that will target early-stage technology companies on the leading edge of cybersecurity innovation. Financial terms of the transaction were not disclosed.

Finjan Holdings Scheduled To Present At Virtual Investor Conference On December 5th
PR Newswire - Wed Nov 20, 3:05PM CST
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") a leading online security and technology company, today announced it is scheduled to present at a Virtual Investor Conference on Thursday, December 5, 2013. To participate and view Finjan Holding's investor presentation please visit http://www.retailinvestorconferences.com. Additional details, including the time of Finjan's Virtual Investor presentation, will be issued via press release the week of December 1, 2013.

Finjan Holdings Subsidiary Issued New U.S. Patent
PR Newswire - Wed Oct 23, 7:30AM CDT
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced its subsidiary Finjan, Inc. ("Finjan") has been issued a new U.S. patent (No. 8,566,580) expiring in 2032. The patent relates to a proprietary system developed by the Company for splitting an SSL connection between two security computers, designed specifically to address network security concerns.

Finjan Holdings To Present At 2013 Gateway Conference
PR Newswire - Mon Sep 09, 7:30AM CDT
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company"), a leading online security and technology company, today announced it is scheduled to present at the 2013 Gateway Conference being held on Tuesday, September 10, 2013 at the Palace Hotel in San Francisco.

Finjan Holdings Subsidiary Files Patent Infringement Lawsuit Against Blue Coat Systems
PR Newswire - Wed Aug 28, 4:03PM CDT
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced its subsidiary, Finjan, Inc. (Finjan) has filed a patent infringement lawsuit against Blue Coat Systems, Inc., alleging infringement of Finjan patents relating to endpoint, web, and network security technologies.

Finjan Holdings Announces Reverse Stock Split
PR Newswire - Wed Aug 21, 12:30PM CDT
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced that a 12-for-1 reverse stock split of the Company's common stock (the "Reverse Stock Split"), previously approved by its Board of Directors and Shareholders, will be effective at the opening of trading on Thursday, August 22, 2013. The Company will continue to trade on the OTC markets under the symbol "FNJN", although the letter "D" will be added to the end of the trading symbol for approximately 20 trading days after the effective time of the split to designate that it is trading on a post-split basis. The Reverse Stock Split will reduce the number of shares of outstanding common stock to approximately 22,368,415 shares.

Finjan Holdings To Participate In Oppenheimer 16th Annual Technology, Internet & Communications Conference
PR Newswire - Mon Aug 12, 7:00AM CDT
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company"), a leading online security and technology company, today announced it is scheduled to participate in one-on-one meetings with investors at the Oppenheimer 16th Annual Technology, Internet & Communications Conference. The conference will be held August 13-14, 2013 at the Four Seasons Hotel in Boston. Management representing the Company will be Phil Hartstein, President, Shimon Steinmetz, Chief Financial Officer and Joshua Weisbord, Director of Investor Relations.

Finjan Holdings Subsidiary Files Patent Infringement Lawsuit Against FireEye
PR Newswire - Tue Jul 09, 7:00AM CDT
Finjan Holdings, Inc. (OTC MKT: FNJN) (the "Company") today announced its subsidiary, Finjan Inc. (Finjan) has filed a patent infringement lawsuit against FireEye, Inc., alleging infringement of Finjan patents relating to endpoint, web, and network security technologies.

Finjan Holdings, Inc. (FNJN) Stock Research Links

FNJN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles